Overview
Carlos Panizo practices in San Sebastian, Spain. Mr. Panizo is highly rated in 5 conditions, according to our data. His top areas of expertise are Non-Hodgkin Lymphoma, Follicular Lymphoma, B-Cell Lymphoma, Splenectomy, and Bone Marrow Transplant.
His clinical research consists of co-authoring 59 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- B-Cell LymphomaMr. Panizo isDistinguished. Learn about B-Cell Lymphoma.
- Follicular LymphomaMr. Panizo isDistinguished. Learn about Follicular Lymphoma.
- Non-Hodgkin LymphomaMr. Panizo isDistinguished. Learn about Non-Hodgkin Lymphoma.
- Advanced
- Diffuse Large B-Cell Lymphoma (DLBCL)
- Mantle Cell Lymphoma (MCL)Mr. Panizo isAdvanced. Learn about Mantle Cell Lymphoma (MCL).
- Experienced
- AgranulocytosisMr. Panizo isExperienced. Learn about Agranulocytosis.
- ArachnoiditisMr. Panizo isExperienced. Learn about Arachnoiditis.
- Bone Marrow TransplantMr. Panizo isExperienced. Learn about Bone Marrow Transplant.
- Burkitt LymphomaMr. Panizo isExperienced. Learn about Burkitt Lymphoma.
- Chronic B-Cell Leukemia (CBCL)Mr. Panizo isExperienced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)Mr. Panizo isExperienced. Learn about Chronic Lymphocytic Leukemia (CLL).